Learn about CVE-2018-18862 involving incorrect access control in BMC Remedy AR System versions 7.1.00 and 9.1.02.003, potentially leading to unauthorized access to sensitive information. Find mitigation steps and best practices for long-term security.
This CVE involves incorrect access control in the ITAM forms of BMC Remedy AR System versions 7.1.00 and 9.1.02.003, affecting specific components.
Understanding CVE-2018-18862
This CVE highlights a vulnerability in BMC Remedy AR System that could lead to unauthorized access to sensitive information.
What is CVE-2018-18862?
The vulnerability in BMC Remedy AR System versions 7.1.00 and 9.1.02.003 allows attackers to exploit incorrect access control in ITAM forms, potentially compromising data confidentiality.
The Impact of CVE-2018-18862
The vulnerability could result in unauthorized users gaining access to sensitive information stored within the affected components of BMC Remedy AR System.
Technical Details of CVE-2018-18862
This section provides detailed technical information about the CVE.
Vulnerability Description
The vulnerability involves incorrect access control in the ITAM forms of BMC Remedy AR System versions 7.1.00 and 9.1.02.003, specifically affecting the TLS%3APLR-Configuration+Details/Default+Admin+View/, AST%3AARServerConnection/Default+Admin+View/, and AR+System+Administration%3A+Server+Information/Default+Admin+View/ components.
Affected Systems and Versions
Exploitation Mechanism
Attackers can exploit this vulnerability by manipulating the access control mechanisms in the ITAM forms, allowing them to gain unauthorized access to sensitive data.
Mitigation and Prevention
Protecting systems from CVE-2018-18862 is crucial to maintaining data security.
Immediate Steps to Take
Long-Term Security Practices
Patching and Updates